![](/img/cover-not-exists.png)
Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guérin with a reduced dose of 27mg in superficial bladder cancer.: BJU Int 2002;89:671–680.
J.A Martinez-Pineiro, N Flores, S Isorna, E Solsona, J.L Sebastián, C Pertusa, L.A Rioja, L Martinez-Pineiro, R Vela, J.E Camacho, J.L Nogueira, I Pereira, L Resel, P Muntanola, F Galvis, N Chesa, J.AVolume:
21
Year:
2003
Language:
english
DOI:
10.1016/s1078-1439(02)00289-2
File:
PDF, 22 KB
english, 2003